Form 4 for DGX Quest Diagnostics
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001599837-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-18 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +15.9K | 136.3K | +13% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $208.16 | -6,184 | 130.2K | -5% | -$1.29M |
| D | 2026-02-20 | 2026-02-18 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +73.2K | 73.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | A | A | 15,857 | $0.00 | 136,337 | D | — | — | (F1) Represents an award of restricted stock units. |
| 2 | Common | Common Stock | 2026-02-18 | F | D | 2,396 | $210.01 | 133,941 | D | — | — | (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2026-02-18 | F | D | 3,788 | $206.99 | 130,153 | D | — | — | (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 4 | Derivative | Non-Qualifed Stock Option (right to buy) | 2026-02-18 | A | A | 73,225 | $0.00 | 73,225 | D | $204.96 · — to 2036-02-18 | 73,225 Common Stock | (F3) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |